Teva Pharmaceutical Industries ADR (NY: TEVA )
10.29 +0.04 (+0.44%) Streaming Delayed Price Updated: 1:58 PM EDT, Sep 26, 2023 Add to My Watchlist
Press Releases about Teva Pharmaceutical Industries ADR
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
February 09, 2022
Research Finds COVID Pandemic Worsened Health Equity Gap
February 01, 2022
Teva Statement Following New York Jury Ruling in Opioids Trial
December 30, 2021
The $11 Trillion Healthcare Industry Is About To Change Forever
November 04, 2021
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 4, 2021 – The $11-trillion healthcare industry is going fully digital, disrupting industry giants & government...
Is This The Most Exciting Medical Breakthrough Of The Decade
October 19, 2021
FN Media Group Presents Oilprice.com Market Commentary London – October 19, 2021 – According to Google’s Health boss David Feinberg… over one billion people a day search Google for health concerns....
Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 2021 Showed AJOVY® (fremanezumab-vfrm) Injection Reduced More Monthly Migraine Days in a Network Meta-Analysis Study with Atogepant and Rimegepant
September 08, 2021
Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache...
August 30, 2021